NRXS CIK: 1933567

Neuraxis, INC

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY22:
−2.30
FY23:
−6.69
FY24:
−6.10
FY25:
−6.43
Change from FY22 to FY25
millions USD
FY22:
−0.06
FY23:
−0.07
FY24:
−0.03
FY25:
−0.13
Change from FY22 to FY25
millions USD
FY22:
2.29
FY23:
6.59
FY24:
9.74
FY25:
7.83
millions USD
FY22:
−0.07
FY23:
−0.18
FY24:
3.62
FY25:
1.27
(positive)
Change from FY22 to FY25
millions USD
FY22:
−2.30
FY23:
−6.72
FY24:
−6.13
FY25:
−6.46

All amounts in millions USD Data source:SEC EDGAR